Alendronate to Prevent Loss of Bronchoprotection in Asthma

NCT02230332 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: Alendronate
DRUG: Placebo

Sponsor

Milton S. Hershey Medical Center

Collaborators

[object Object]